Corebridge Financial Inc. Lowers Position in UnitedHealth Group Incorporated (NYSE:UNH)

Corebridge Financial Inc. lessened its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 5.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 211,510 shares of the healthcare conglomerate's stock after selling 13,167 shares during the period. UnitedHealth Group comprises about 0.6% of Corebridge Financial Inc.'s portfolio, making the stock its 18th largest holding. Corebridge Financial Inc.'s holdings in UnitedHealth Group were worth $106,994,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of UNH. Howard Capital Management Group LLC bought a new stake in shares of UnitedHealth Group in the third quarter valued at approximately $341,000. Principal Financial Group Inc. lifted its stake in shares of UnitedHealth Group by 11.3% in the 3rd quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate's stock valued at $1,039,933,000 after acquiring an additional 180,479 shares during the last quarter. Kingsview Wealth Management LLC grew its holdings in shares of UnitedHealth Group by 4.1% during the third quarter. Kingsview Wealth Management LLC now owns 10,461 shares of the healthcare conglomerate's stock worth $6,116,000 after purchasing an additional 416 shares during the last quarter. Algert Global LLC acquired a new position in UnitedHealth Group in the 3rd quarter valued at approximately $1,763,000. Finally, Truepoint Inc. lifted its stake in shares of UnitedHealth Group by 45.2% in the third quarter. Truepoint Inc. now owns 1,082 shares of the healthcare conglomerate's stock worth $633,000 after acquiring an additional 337 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.

Remove Ads

Analyst Ratings Changes

UNH has been the topic of several recent analyst reports. Truist Financial dropped their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating on the stock in a report on Monday, January 6th. KeyCorp restated an "overweight" rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Deutsche Bank Aktiengesellschaft upped their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the company a "buy" rating in a research note on Tuesday, December 3rd. Hsbc Global Res upgraded shares of UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research note on Friday, January 10th. Finally, HSBC upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price objective for the company in a research note on Friday, January 10th. Twenty equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Buy" and an average target price of $629.32.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the company's stock in a transaction on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. 0.33% of the stock is currently owned by corporate insiders.

UnitedHealth Group Price Performance

Shares of NYSE UNH traded down $2.92 during trading hours on Tuesday, reaching $513.58. 3,014,727 shares of the stock traded hands, compared to its average volume of 4,091,387. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company's 50-day simple moving average is $509.10 and its two-hundred day simple moving average is $545.56. The company has a market capitalization of $469.78 billion, a P/E ratio of 33.13, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter last year, the firm earned $5.83 EPS. The firm's quarterly revenue was up 6.8% compared to the same quarter last year. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.64%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's payout ratio is 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.